Karol Axcrona

About

Karol Axcrona is a prominent urologic oncologist whose research centers on improving outcomes and quality of life for men with prostate cancer, particularly those with high-risk disease. His major contributions span three key areas: advancing surgical techniques, pioneering immunotherapy, and systematically evaluating post-treatment adverse effects. Notably, Axcrona led a long-term Phase I/II study (30 citations) demonstrating the safety and potential efficacy of an adjuvant dendritic cell vaccine for high-risk prostate cancer patients after radical prostatectomy—a first-in-man trial that opened new avenues for personalized immunotherapy. His work on routine pelvic MRI (25 citations) established its clinical value for detecting extraprostatic tumor extension, directly impacting surgical planning. Axcrona has also produced influential research on post-treatment bother problems (30 citations) and functional outcomes, including comparative studies of erectile function and orgasmic ability after robot-assisted laparoscopic prostatectomy. His innovative methodological work on prospective adverse effect studies (9 citations) has provided frameworks for assessing recovery of sexual, urinary, and bowel function. With over 140 cumulative citations across his most-cited papers, Axcrona’s research has shaped contemporary understanding of both the oncologic and quality-of-life dimensions of prostate cancer treatment, making him a key voice in patient-centered urologic oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   Bother problems in prostate cancer patients after curative treatment

   30 citations · 2012
2. 2
   Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy

   30 citations · 2021
3. 3
   Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance

   25 citations · 2012
4. 4
   A comparative study of erectile function and use of erectile aids in high-risk prostate cancer patients after robot-assisted laparoscopic prostatectomy

   11 citations · 2015
5. 5
   Ability to Reach Orgasm in Patients With Prostate Cancer Treated With Robot-assisted Laparoscopic Prostatectomy

   11 citations · 2016
6. 6
   Robot-assisted radical prostatectomy of clinical high-risk patients with prostate cancer: A controlled study of operative and short-term postoperative events

   9 citations · 2013
7. 7
   Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones

   9 citations · 2011
8. 8
   A cross-sectional study of current work ability after radical prostatectomy

   8 citations · 2020
9. 9
   Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center

   7 citations · 2010
10. 10
    The EPIC-26 domain scores after radical prostatectomy are associated with the personality trait of neuroticism

    6 citations · 2020

Key Collaborators

Contact & Links